Recce Pharmaceuticals: Appoints new CEO

  • Recce Pharmaceuticals (RCE) Board of Directors has unanimously appointed James Graham as the company’s new CEO
  • James has served as Recce’s Executive Director of Marketing and Business Development for the last five years
  • In addition to his new duties as CEO, James will continue to serve as a Director on the Board
  • His appointment takes effect on August 28, and comes with an annual salary of $300,000
  • James will oversee the company as it approaches a number of critical milestones, including a clinical trial and COVID-19 studies
  • Recce Pharmaceuticals closed 0.37 per cent in the red for $1.36 each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Business Banking Fintech Slash Reaches Unicorn Status

The fintech startup achieves a valuation of over $1 billion.Highlights: Slash has been valued at over $1 billion.The...

Amex Strengthens Digital Services with AI Expense Management Acquisition

American Express to acquire Hyper to enhance its business offerings.Highlights: American Express announces the acquisition of AI startup...

UK Banks Strengthen Cybersecurity with Anthropics Mythos Model

New collaboration enhances banks' defense against cyber threats.Highlights: UK banks to access Anthropics Mythos model in the upcoming...

UK Banks to Gain Access to Anthropic Cybersecurity Model Next Week

New collaboration enhances cybersecurity for UK banking institutions.Highlights: UK banks set to access Anthropic's cybersecurity model soon.Collaboration aims...